(BCS) Barclays - Ratings and Ratios
Retail Banking, Credit Cards, Investment Banking, Wealth Management, Lending
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 31.5% |
| Value at Risk 5%th | 53.4% |
| Relative Tail Risk | 3.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.69 |
| Alpha | 50.66 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.439 |
| Beta | 1.123 |
| Beta Downside | 1.225 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.96% |
| Mean DD | 7.03% |
| Median DD | 3.64% |
Description: BCS Barclays September 26, 2025
Barclays PLC (NYSE: BCS) is a globally diversified financial services firm headquartered in London, operating across retail, corporate, private, and investment banking, as well as wealth and investment management, with a presence in Europe, the Americas, Africa, the Middle East, and Asia.
The business is structured into five operating segments: Barclays UK, Barclays UK Corporate Bank, Barclays Private Bank & Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank, each delivering a mix of deposit-taking, lending, advisory, and securities-trading services.
Key recent performance metrics (as of FY 2023) include a CET1 capital ratio of 13.5 % (well above the 10.5 % regulatory minimum), a net interest margin of 2.2 % reflecting a higher-for-longer rate environment, and a return on equity (ROE) of 7.8 %, indicating modest profitability relative to peers.
Sector drivers that materially affect Barclays are the trajectory of central-bank policy rates (especially the Bank of England’s stance on inflation), the pace of digital-banking adoption which can compress costs but requires sustained technology investment, and regulatory capital requirements that influence dividend policy and share-buyback capacity.
Assuming the current macro backdrop of elevated rates persists, Barclays’ net interest income should remain a primary earnings catalyst, while credit-risk metrics will need close monitoring given potential stress in the UK commercial-property market.
For a deeper, data-rich assessment of how these factors translate into valuation outlooks, you might find ValueRay’s analyst dashboards useful for drilling into scenario-based forecasts.
BCS Stock Overview
| Market Cap in USD | 72,448m |
| Sub-Industry | Diversified Banks |
| IPO / Inception | 1986-09-10 |
| Return 12m vs S&P 500 | 45.8% |
| Analyst Rating | 4.0 of 5 |
BCS Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 2.00% |
| Yield on Cost 5y | 6.91% |
| Yield CAGR 5y | 7.46% |
| Payout Consistency | 86.7% |
| Payout Ratio | 21.1% |
BCS Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 45.85% |
| CAGR/Max DD Calmar Ratio | 1.53 |
| CAGR/Mean DD Pain Ratio | 6.52 |
| Current Volume | 4351.6k |
| Average Volume | 5505.1k |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (6.91b TTM) > 0 and > 6% of Revenue (6% = 1.64b TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 0.51pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -809.9% (prev -820.9%; Δ 10.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 27.41b > Net Income 6.91b (YES >=105%, WARN >=100%) |
| Net Debt (-252.57b) to EBITDA (9.53b) ratio: -26.49 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.51b) change vs 12m ago -4.12% (target <= -2.0% for YES) |
| Gross Margin 6.97% (prev -33.73%; Δ 40.70pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1.73% (prev 1.60%; Δ 0.13pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.01 (EBITDA TTM 9.53b / Interest Expense TTM 25.39b) >= 6 (WARN >= 3) |
Altman Z'' -0.72
| (A) -0.14 = (Total Current Assets 867.76b - Total Current Liabilities 1088.80b) / Total Assets 1629.15b |
| (B) 0.04 = Retained Earnings (Balance) 58.37b / Total Assets 1629.15b |
| (C) -0.00 = EBIT TTM -219.0m / Avg Total Assets 1580.14b |
| (D) 0.05 = Book Value of Equity 76.39b / Total Liabilities 1552.31b |
| Total Rating: -0.72 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 49.01
| 1. Piotroski 3.0pt |
| 2. FCF Yield -0.83% |
| 3. FCF Margin 20.30% |
| 4. Debt/Equity 1.88 |
| 5. Debt/Ebitda -26.49 |
| 6. ROIC - WACC (= -13.41)% |
| 7. RoE 9.25% |
| 8. Rev. Trend 44.84% |
| 9. EPS Trend 25.42% |
What is the price of BCS shares?
Over the past week, the price has changed by +2.84%, over one month by +1.97%, over three months by +6.32% and over the past year by +66.71%.
Is BCS a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.7 | -0.1% |
| Analysts Target Price | 21.7 | -0.1% |
| ValueRay Target Price | 29.7 | 37% |
BCS Fundamental Data Overview November 24, 2025
P/E Trailing = 9.784
P/E Forward = 6.854
P/S = 2.7842
P/B = 0.7246
P/EG = 1.0385
Beta = 0.911
Revenue TTM = 27.29b GBP
EBIT TTM = -219.0m GBP
EBITDA TTM = 9.53b GBP
Long Term Debt = 74.96b GBP (from longTermDebt, last fiscal year)
Short Term Debt = 35.40b GBP (from shortTermDebt, last quarter)
Debt = 143.98b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -252.57b GBP (from netDebt column, last quarter)
Enterprise Value = -668.32b GBP (55.24b + Debt 143.98b - CCE 867.54b)
Interest Coverage Ratio = -0.01 (Ebit TTM -219.0m / Interest Expense TTM 25.39b)
FCF Yield = -0.83% (FCF TTM 5.54b / Enterprise Value -668.32b)
FCF Margin = 20.30% (FCF TTM 5.54b / Revenue TTM 27.29b)
Net Margin = 25.33% (Net Income TTM 6.91b / Revenue TTM 27.29b)
Gross Margin = 6.97% ((Revenue TTM 27.29b - Cost of Revenue TTM 25.39b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 100.0%)
Tobins Q-Ratio = -0.41 (set to none) (Enterprise Value -668.32b / Total Assets 1629.15b)
Interest Expense / Debt = 17.63% (Interest Expense 25.39b / Debt 143.98b)
Taxrate = 17.57% (365.0m / 2.08b)
NOPAT = -180.5m (EBIT -219.0m * (1 - 17.57%)) [loss with tax shield]
Current Ratio = 0.80 (Total Current Assets 867.76b / Total Current Liabilities 1088.80b)
Debt / Equity = 1.88 (Debt 143.98b / totalStockholderEquity, last quarter 76.39b)
Debt / EBITDA = -26.49 (Net Debt -252.57b / EBITDA 9.53b)
Debt / FCF = -45.60 (Net Debt -252.57b / FCF TTM 5.54b)
Total Stockholder Equity = 74.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.42% (Net Income 6.91b / Total Assets 1629.15b)
RoE = 9.25% (Net Income TTM 6.91b / Total Stockholder Equity 74.75b)
RoCE = -0.15% (EBIT -219.0m / Capital Employed (Equity 74.75b + L.T.Debt 74.96b))
RoIC = -0.09% (negative operating profit) (NOPAT -180.5m / Invested Capital 208.25b)
WACC = 13.32% (E(55.24b)/V(199.23b) * Re(10.15%) + D(143.98b)/V(199.23b) * Rd(17.63%) * (1-Tc(0.18)))
Discount Rate = 10.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -51.77%
[DCF Debug] Terminal Value 61.58% ; FCFE base≈5.54b ; Y1≈3.64b ; Y5≈1.66b
Fair Price DCF = 6.90 (DCF Value 23.99b / Shares Outstanding 3.48b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 25.42 | EPS CAGR: 23.46% | SUE: -0.54 | # QB: 0
Revenue Correlation: 44.84 | Revenue CAGR: 11.58% | SUE: 0.02 | # QB: 0
Additional Sources for BCS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle